1. Home
  2. ACTU vs AMPY Comparison

ACTU vs AMPY Comparison

Compare ACTU & AMPY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ACTU
  • AMPY
  • Stock Information
  • Founded
  • ACTU 2015
  • AMPY 2011
  • Country
  • ACTU United States
  • AMPY United States
  • Employees
  • ACTU N/A
  • AMPY N/A
  • Industry
  • ACTU
  • AMPY Oil & Gas Production
  • Sector
  • ACTU
  • AMPY Energy
  • Exchange
  • ACTU NYSE
  • AMPY Nasdaq
  • Market Cap
  • ACTU 135.0M
  • AMPY 118.2M
  • IPO Year
  • ACTU 2024
  • AMPY 2011
  • Fundamental
  • Price
  • ACTU $10.35
  • AMPY $2.90
  • Analyst Decision
  • ACTU Strong Buy
  • AMPY Strong Buy
  • Analyst Count
  • ACTU 1
  • AMPY 2
  • Target Price
  • ACTU $20.00
  • AMPY $10.25
  • AVG Volume (30 Days)
  • ACTU 71.1K
  • AMPY 1.4M
  • Earning Date
  • ACTU 05-21-2025
  • AMPY 05-12-2025
  • Dividend Yield
  • ACTU N/A
  • AMPY N/A
  • EPS Growth
  • ACTU N/A
  • AMPY N/A
  • EPS
  • ACTU N/A
  • AMPY 0.31
  • Revenue
  • ACTU N/A
  • AMPY $294,680,100.00
  • Revenue This Year
  • ACTU N/A
  • AMPY $17.78
  • Revenue Next Year
  • ACTU N/A
  • AMPY $31.78
  • P/E Ratio
  • ACTU N/A
  • AMPY $9.29
  • Revenue Growth
  • ACTU N/A
  • AMPY 1.72
  • 52 Week Low
  • ACTU $5.51
  • AMPY $2.27
  • 52 Week High
  • ACTU $11.73
  • AMPY $8.15
  • Technical
  • Relative Strength Index (RSI)
  • ACTU N/A
  • AMPY 50.13
  • Support Level
  • ACTU N/A
  • AMPY $2.60
  • Resistance Level
  • ACTU N/A
  • AMPY $2.82
  • Average True Range (ATR)
  • ACTU 0.00
  • AMPY 0.20
  • MACD
  • ACTU 0.00
  • AMPY 0.09
  • Stochastic Oscillator
  • ACTU 0.00
  • AMPY 57.96

About ACTU ACTUATE THERAPEUTICS INC

Actuate Therapeutics Inc is a clinical stage biopharmaceutical company focused on developing therapies for the treatment of high impact, difficult to treat cancers through the inhibition of glycogen synthase kinase-3 (GSK-3). It is developing elraglusib (formerly 9-ING-41), a small molecule that is designed to enter cancer cells and block the function of the enzyme GSK-3B, a master regulator of complex biological signaling cascades, including those mediated by oncogenes, that lead to tumor cell survival, growth, migration, and invasion.

About AMPY Amplify Energy Corp.

Amplify Energy Corp is an independent oil and natural gas company engaged in the acquisition, development, exploitation, and production of oil and natural gas properties in the United States. The company's oil and natural gas properties are located in large, mature oil and natural gas reservoirs. The company assets consists of producing oil and natural gas properties located in Oklahoma, the Rockies, federal waters offshore Southern California, East Texas/North Louisiana and Eagle Ford.

Share on Social Networks: